Archive for April, 2002

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting the technology? When should it make the leap from investigative, experimental technique to industry standard? And should the FDA start using microarray data to make critical decisions about the safety and efficacy of new drugs?


Click here for reuse options!
Copyright 2002 Biotechblog

Research 'leak' hits Genentech

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next month’s American Society of Clinical Oncology appeared to have been leaked.


Click here for reuse options!
Copyright 2002 Biotechblog

Research ‘leak’ hits Genentech

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next month’s American Society of Clinical Oncology appeared to have been leaked.


Click here for reuse options!
Copyright 2002 Biotechblog

As Tony White Reads Resumes, Industry Buzzes Around Core Four

As Tony White Reads Resumes, Industry Buzzes Around Core Four It’s been two-and-a-half months since J. Craig walked away from Celera and Applera chief Tony White is still skimming resumes. Though Celera has been characteristically mum about potential prospects or their status, an initial shortlist of four likely candidates compiled by GenomeWeb from interviews with […]


Click here for reuse options!
Copyright 2002 Biotechblog

President Presses Senate to Ban All Human Cloning

President Presses Senate to Ban All Human Cloning Declaring that “life is a creation, not a commodity,” Bush pressed the Democratic Senate to adopt legislation that would outlaw the cloning of microscopic human embryos for research into new medical therapies, in addition to outlawing the creation of cloned babies.


Click here for reuse options!
Copyright 2002 Biotechblog

7 drug makers unveil elderly discounts

7 drug makers unveil elderly discounts Under pressure from consumers and lawmakers over drug prices, Abbott Laboratories and six other manufacturers are launching a discount card for seniors that would lop 20 percent to 40 percent off the price of more than 130 commonly prescribed medicines.


Click here for reuse options!
Copyright 2002 Biotechblog

Survival of fittest is new mode for biotechs

Survival of fittest is new mode for biotechs Consolidation won’t slow, and that’s no bad thing, industry watchers say


Click here for reuse options!
Copyright 2002 Biotechblog

New `greenhouses' to promote biotechnology businesses

New `greenhouses’ to promote biotechnology businesses “With fanfare that extended beyond state boundaries into prime technological turf, Pennsylvania on Wednesday began channeling $100 million to three life-sciences “greenhouses” meant to cultivate biotechnology business in the state. “


Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: